RenovoRx raises $11.1M, believes it has regained Nasdaq equity compliance

RenovoRx, Inc.

Closed $11.1M private placement of common stock and warrants on April 11, 2024.
Company previously faced delisting for stockholders' equity below $2.5M.
Believes new capital brings it into compliance; awaiting Nasdaq confirmation.
If confirmed, monitoring continues; non-compliance could reappear at next periodic report.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.